PCN55 THE IMPACT OF 21-GENE RT-PCRASSAY ON REAL LIFE TREATMENT DECISIONS IN N−, ER+ EARLY-STAGE BREAST CANCER PATIENTS: IT'S IMPLICATION FOR BUDGET IMPACT ANALYSIS
| Autor: | Hammerman, A, Klang, SH, Liebermann, N, Efrat, N |
|---|---|
| Zdroj: | In Value in Health 2007 10(6):A339-A339 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect